Article No. 404
16 December 2020
‘Your World in Research’
December 2020 Additions to Our aHUS Research Scrolls
Since 2020 or ‘the Year of COVID-19’ has been challenging on many fronts, it seems fitting to ring out this year featuring a new publication by Bernabeu et al (Nov 2020). Its title is a great preview of the contents, Atypical Hemolytic Uremic Syndrome: New Challenges in the Complement Blockage Era, but additionally it underscores key topics for aHUS diagnosis and treatment. Among the citations listed in the Bernabeu paper one referenced, #73 Raina et al, 2019, has a section written by the aHUS Alliance Global Action team headed ‘Eculizumab Challenges: Patients’ Perspective’.
Here’s a small selection of new aHUS research from various topics of high interest released since aHUS Awareness Day (24 Sept 2020). Underlying themes in many underscore continued difficulty with diagnosis, treatment considerations and disease management, and a lack of drug access in many nations. We invite you to view many more publications newly added to our Research & Publications scrolls, which are categorized by topic. The ‘New Research’ scroll heads the page, created so that readers can easily access many of the main aHUS publications which have been released over this past year. Those interested into a ‘deep dive’ into a specific interest area will find multiple years of aHUS research on scrolls for these topics: Critical Care, Thrombotic Microangiopathy (TMA), Extra Renal: Effects on the Body, Pregnancy, Transplants, Genetics, Research in Specific Nations, Case Studies, Complement, Patient Registry: Publications, Drug discovery/Research, Summary articles/Literature Reviews, Consensus Documents/Guidelines, Secondary aHUS, Triggers, Treatment, Diagnosis, and Varied Topics (other).
Hundreds of aHUS-specific publications are listed on our Research & Publications scrolls, but do alert the aHUS Alliance Global Action team if our volunteers have missed a research paper. Articles on various publications and scroll topics exist, featuring original content written by an international team of aHUS patients and family caregivers, with many key website articles listed on our website’s aHUS Resource Page.
While many are aware that atypical HUS is an ultra rare disease, did you know that aHUS is considered a complement-mediated TMA? Research relevant to aHUS can be found under the headings of rare diseases, TMA, complement, and more – and the variety of terminology can make finding information difficult. Here’s a small sample of aHUS research that’s been released in the last two months of 2020. We invite our readers to explore our Research & Publications page, and to visit our Atypical HUS Resource Page to learn more about how those topics affect aHUS patients and guide their clinical care.
Treatment & Diagnosis
Contact Us – Info@aHUSallianceAction.org
Sign up for your Free Copies of
The aHUS Global Advocate
Direct to Your Inbox – Keep Connected with aHUS Info & News